Home|Journals|Articles by Year|Audio Abstracts
 

4 articles found.


Publishing Year(s)



Click to Change Year(s)

Journal(s)



Click to Change Journal(s)

  1. The Effect of Darapladib Therapy for the Expression of Lp-PLA2 in Dyslipidemia and Type 2 Diabetes Mellitus Atherosclerosis Model
    Titin Andri Wihastuti, Rosaria Dian Lestari, Teuku Heriansyah
    Journal of Applied Pharmaceutical Science. 2018; 8(4): 64-70.
  2. Lp-PLA2 Selective Inhibitor (Darapladib) Effect in Lowering Insulin Resistance and Aortic Tissue Inflammation at Type 2 Diabetes Mellitus
    Titin Andri Wihastuti, Dinda Zahra Putri Andiyani, Sri Andarini, Teuku Heriansyah
    Journal of Applied Pharmaceutical Science. 2017; 7(12): 110-115.
  3. Effects of subchronic exposure of PSP Ganoderma lucidum on renal function and histopathology feature in Rattus novergicus Wistar strain
    Titin Andri Wihastuti, Djanggan Sargowo, Mohammad Aris Widodo, Teuku Heriansyah, Setyowati Soeharto, Kenti Wantri Anita, Novita Qurrota A’ini
    National Journal of Physiology, Pharmacy and Pharmacology. 2015; 5(4): 296-302.
  4. Atherogenesis inhibition by darapladib administration in dyslipidemia model Sprague–Dawley rats
    Teuku Heriansyah, Titin Andri Wihastuti, Kenty Wantri Anita, Agustin Iskandar, Riski Bagus Suhendra, Patan Ahmad Setiabudi, Lintang Widya Sishartami
    National Journal of Physiology, Pharmacy and Pharmacology. 2016; 6(1): 52-58.


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.